Study Links Glucosamine to Faster Alzheimer's Decline, Raising Concerns
A recent study conducted by researchers at the University of Florida has found a potential link between the use of glucosamine, a common supplement for joint health, and an accelerated decline in Alzheimer's disease. The study, published in Nature Metabolism, utilized AI to analyze health records from 2012 to 2024, focusing on individuals with Alzheimer's or mild cognitive impairment (MCI). The findings suggest that glucosamine users with MCI had a 25% higher likelihood of developing dementia compared to non-users. The research indicates that glucosamine may exacerbate a 'sugar-tagging' mechanism in the brain, which is already disrupted in Alzheimer's, potentially worsening the condition. While the study does not establish a direct causal relationship, it highlights a concerning association that warrants further investigation. 
